Interferon gene stimulating factor targeted radioactive PET imaging agent

A technology of targeting imaging agents and stimulating factors, applied in the field of medical imaging, can solve the problems of lack of molecular imaging probes targeting STING, achieve good chemical stability, simple and easy preparation methods, and reduce radiation damage.

Active Publication Date: 2021-09-24
THE FIFTH AFFILIATED HOSPITAL SUN YAT SEN UNIV
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there is no report on the visualization of STING in tumors in vivo to guide clinica

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Interferon gene stimulating factor targeted radioactive PET imaging agent
  • Interferon gene stimulating factor targeted radioactive PET imaging agent
  • Interferon gene stimulating factor targeted radioactive PET imaging agent

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] Synthesis of compound 3-1: when n=1 in the general structural formula, it is compound 3-1, and its labeling route and preparation method are as follows:

[0027]

[0028] The specific marking process includes the following steps:

[0029] 1) Preparation

[0030] Take 1 mL of Kryptofix222 / K prepared in the second step 2 CO 3 Wash the QMA cartridge with the mixed solution of the mixed solution, and collect the eluent; heat the nitrogen blower to 110°C, dry the eluent, and then add 0.5 mL of anhydrous acetonitrile continuously, remove the remaining water by azeotropic distillation, press Cover and cool to room temperature for later use;

[0031] 2) Labeling of compound 2-1:

[0032] Dissolve 2 mg of compound 1-1 in 0.2 mL of anhydrous acetonitrile, extract it with a 1 mL syringe, and add it to the dried [ 18 F] Fluoride ion, Kryptofix222 / K 2 CO 3 In the mixture, the reaction mixture was heated at 90 °C for 20 minutes. After the reaction mixture was cooled to roo...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Specific activityaaaaaaaaaa
Login to view more

Abstract

The invention discloses an interferon gene stimulating factor (STING) targeted imaging agent. The imaging agent is based on a benzothiophene structure, is labeled by radionuclide 18F, can be used for PET imaging of interferon gene stimulating factors, and has a structural general formula as shown in a formula A. In the formula, n is equal to 1-5. In the formula A, the benzothiophene structure is used as a targeted group, polyethylene glycol is used as a hydrophilic group, and 18F is a radioactive group. The molecular targeting imaging agent has excellent targeting and specificity on interferon gene stimulating factors, and can be used for monitoring immune response generated by inflammation and tumors through PET imaging. The molecule can specifically distinguish immunoreactions with different severity degrees, and meets the condition of serving as an immune monitoring developer.

Description

technical field [0001] The invention belongs to the technical field of medical imaging, and in particular relates to a PET imaging agent targeting an interferon gene stimulating factor and a marking method and application thereof. Background technique [0002] Inflammation plays an important role in host defense as part of innate immunity and is involved in cellular recovery and regeneration. Inflammation is also closely related to many diseases, such as rheumatoid arthritis (RA), inflammatory bowel disease (IBD), atherosclerosis, asthma, lung injury, neurodegenerative diseases (such as Alzheimer's disease), and Cancer, etc., but the pathogenic mechanism is still unclear. Tumor immunotherapy is an effective treatment method to restore the body's normal anti-tumor immune response, control and eliminate tumors. But not all tumor patients can benefit from it, which is mainly due to differences in immune responses in the tumor microenvironment of different patients. [0003] ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D333/70C07B59/00A61K51/04A61K101/02
CPCC07D333/70C07B59/002A61K51/0431C07B2200/05
Inventor 单鸿许多李丹肖义泰朱天星
Owner THE FIFTH AFFILIATED HOSPITAL SUN YAT SEN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products